These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21278247)

  • 21. DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial.
    Sundar R; Ng A; Zouridis H; Padmanabhan N; Sheng T; Zhang S; Lee MH; Ooi WF; Qamra A; Inam I; Hewitt LC; So JB; Koh V; Nankivell MG; Langley RE; Allum WH; Cunningham D; Rozen SG; Yong WP; Grabsch HI; Tan P
    Eur J Cancer; 2019 Dec; 123():48-57. PubMed ID: 31655359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
    Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
    Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients.
    Li M; Sun X; Yao H; Chen W; Zhang F; Gao S; Zou X; Chen J; Qiu S; Wei H; Hu Z; Chen W
    Toxicol Appl Pharmacol; 2021 Sep; 427():115657. PubMed ID: 34332992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index.
    Hou X; He X; Wang K; Hou N; Fu J; Jia G; Zuo X; Xiong H; Pang M
    Cell Physiol Biochem; 2018; 49(5):1703-1716. PubMed ID: 30248669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
    Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
    PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer.
    Dai QX; Liao YH; Deng XH; Xiao XL; Zhang L; Zhou L
    Clin Chim Acta; 2020 Sep; 508():54-60. PubMed ID: 32423860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Chan AT; Schernhammer ES; Giovannucci EL; Fuchs CS
    J Natl Cancer Inst; 2008 Dec; 100(23):1734-8. PubMed ID: 19033568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma.
    Huang H; Fu J; Zhang L; Xu J; Li D; Onwuka JU; Zhang D; Zhao L; Sun S; Zhu L; Zheng T; Jia C; Cui B; Zhao Y
    Front Oncol; 2021; 11():629860. PubMed ID: 34178621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.
    Swets M; Zaalberg A; Boot A; van Wezel T; Frouws MA; Bastiaannet E; Gelderblom H; van de Velde CJ; Kuppen PJ
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.
    Fu T; Pappou EP; Guzzetta AA; Calmon Mde F; Sun L; Herrera A; Li F; Wolfgang CL; Baylin SB; Iacobuzio-Donahue CA; Tong W; Ahuja N
    Ann Surg; 2016 Feb; 263(2):337-44. PubMed ID: 25822686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG methylation signature predicts prognosis in breast cancer.
    Du T; Liu B; Wang Z; Wan X; Wu Y
    Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide screening for understanding the role of DNA methylation in colorectal cancer.
    Sipos F; Mũzes G; Patai AV; Fũri I; Péterfia B; Hollósi P; Molnár B; Tulassay Z
    Epigenomics; 2013; 5(5):569-81. PubMed ID: 24059802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.
    Jiang W; Liu N; Chen XZ; Sun Y; Li B; Ren XY; Qin WF; Jiang N; Xu YF; Li YQ; Ren J; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Mai HQ; Zeng MS; Kang TB; Jia WH; Shao JY; Ma J
    Mol Cancer Ther; 2015 Dec; 14(12):2864-73. PubMed ID: 26443805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A network-based, integrative approach to identify genes with aberrant co-methylation in colorectal cancer.
    Li Y; Xu J; Ju H; Xiao Y; Chen H; Lv J; Shao T; Bai J; Zhang Y; Wang L; Wang X; Ren H; Li X
    Mol Biosyst; 2014 Feb; 10(2):180-90. PubMed ID: 24317156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving closer to a prognostic DNA methylation signature in colon cancer.
    Carmona FJ; Esteller M
    Clin Cancer Res; 2011 Mar; 17(6):1215-7. PubMed ID: 21411436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
    Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.